Skip to main content

Articles

1215 result(s) for 'cancer' within Journal of Ovarian Research

Page 11 of 25

  1. In a previous analysis on the patients with ovarian cancers, we have found that clusterin is a biomarker associated with ovarian cancer in vivo...and may be a prognostic factor associated with adverse outcome. He...

    Authors: Yanxia Fu, Yingrong Lai, Junfeng Liu, Xingyang Liu, Zeshan You and Guofen Yang
    Citation: Journal of Ovarian Research 2015 8:59
  2. Increasing researches have demonstrated the critical functions of MicroRNAs (miRNAs) in the progression of malignant tumors, including ovarian cancer. It was reported that miR-552 was an important oncogene in bot...

    Authors: Wenman Zhao, Tao Han, Bao Li, Qianyun Ma, Pinghua Yang and Hengyu Li
    Citation: Journal of Ovarian Research 2019 12:121
  3. Synuclein gamma (SNCG) expression is associated with advanced disease and chemoresistance in multiple solid tumors. Our goal was to determine if SNCG protein expression in ovarian cancer was correlated with clini...

    Authors: Anna Strohl, Kristina Mori, Stacey Akers, Wiam Bshara, Barbara Buttin, Peter J. Frederick, Irene B. Helenowski, Carl D Morrison, Kunle Odunsi, Julian C. Schink, Denise M. Scholtens, Jian-Jun Wei and J. Julie Kim
    Citation: Journal of Ovarian Research 2016 9:75
  4. Glycosphingolipids are important compounds of the plasma membrane of mammalian cells and a number of them have been associated with malignant transformation and progression, reinforcing tumour aggressiveness and ...

    Authors: Tatiana Pochechueva, Shahidul Alam, Andreas Schötzau, Alexander Chinarev, Nicolai V. Bovin, Neville F. Hacker, Francis Jacob and Viola Heinzelmann-Schwarz
    Citation: Journal of Ovarian Research 2017 10:8
  5. Ovarian cancer is the most lethal of gynecological malignancies. ... FTIR spectra of normal and several heterogeneous ovarian cancer cell lines as well as ovarian cancer tissue samples were compared in the spectr...

    Authors: Lei Li, Xiaoning Bi, Hengzi Sun, Simiao Liu, Mei Yu, Ying Zhang, Shifu Weng, Limin Yang, Yanan Bao, Jinguang Wu, Yizhuang Xu and Keng Shen
    Citation: Journal of Ovarian Research 2018 11:64
  6. We aimed to examine the expression of miR-1307 in chemosensitive and chemoresistant epithelial ovarian cancer tissues and cell lines and to analyze ... the clinicopathological significance of miR-1307 in ovarian

    Authors: Yingying Zhou, Min Wang, Jianlei Wu, Zhihui Jie, Shuang Chang and Ting Shuang
    Citation: Journal of Ovarian Research 2015 8:23
  7. Poly (ADP-ribose) polymerase (PARP) inhibitor, is a milestone in treatment of ovarian cancer. However, there is no real world ... effects and short-term efficacy in advanced ovarian cancer patients who administer...

    Authors: Jing Ni, Xianzhong Cheng, Rui Zhou, Xia Xu, Wenwen Guo and Xiaoxiang Chen
    Citation: Journal of Ovarian Research 2019 12:117
  8. Recent studies have shown that microRNAs may regulate the ABCB1 gene (ATP-binding cassette, sub-family B [MDR/TAP], member 1). Computational programs have predicted that the 3’-untranslated region (3’-UTR) of ABC...

    Authors: Kai-Xuan Sun, Jin-Wen Jiao, Shuo Chen, Bo-Liang Liu and Yang Zhao
    Citation: Journal of Ovarian Research 2015 8:80
  9. The down-regulation of E-cadherin gene (CDH1...) expression has been regarded as an important event in cancer invasion and metastasis. However, the association...CDH1 promoter methylation and ovarian cancer remai...

    Authors: Qiang Wang, Bing Wang, Yun-mei Zhang and Wei Wang
    Citation: Journal of Ovarian Research 2016 9:23
  10. Increased activity of the chaperones Hsp70 and Hsp90 is a common feature of solid tumours. Translocase of the outer mitochondrial membrane 34 (Tomm34) is a cochaperone of both Hsp70 and Hsp90 that was found to be...

    Authors: Petr Muller, Philip J. Coates, Rudolf Nenutil, Filip Trcka, Roman Hrstka, Josef Chovanec, Veronika Brychtova and Borivoj Vojtesek
    Citation: Journal of Ovarian Research 2019 12:30
  11. Previous studies about the prognostic value of the HIPEC have yielded controversial results. Therefore, this study aims to assess the impact of HIPEC on patients with ovarian cancer.

    Authors: Guyu Zhang, Yimin Zhu, Chongdong Liu, Guangming Chao, Ran Cui and Zhenyu Zhang
    Citation: Journal of Ovarian Research 2019 12:33
  12. ...miRNAs are proved to have causal roles in tumorgenesis involving various types of human cancers, but the mechanism is not clear. ... effect of miRNAs on the development of ovarian cancer and the underlying mec...

    Authors: Huanchun Ying, Jing Lyu, Tianshu Ying, Jun Li, Shanshan Jin, Jingru Shao, Lili Wang and Hongying Xu
    Citation: Journal of Ovarian Research 2014 7:226

    The Retraction Note to this article has been published in Journal of Ovarian Research 2015 8:17

  13. Ovarian cancer during pregnancy is relatively rare and treatment ... chemotherapy. Multidisciplinary management of advanced epithelial ovarian cancer in pregnant patients with strong desire of...

    Authors: Tianmin Xu, Liang Wang, Yan Jia, Zanhui Jia, Zhuo Li, Shaohai Cui and Manhua Cui
    Citation: Journal of Ovarian Research 2019 12:108
  14. Gynecological cancers are among the leading causes of cancer-associated mortality worldwide. While the number of ... of curcumin and its novel analogues on gynecological cancers. Moreover, novel formulations of c...

    Authors: Mohammad Hossein Pourhanifeh, Maryam Darvish, Javad Tabatabaeian, Mahboobeh Rabbani Fard, Reza Mottaghi, Mohammad Javad Azadchehr, Moghaddaseh Jahanshahi, Amirhossein Sahebkar and Hamed Mirzaei
    Citation: Journal of Ovarian Research 2020 13:130
  15. Prognostic biomarkers are highly needed to properly manage patients with cancer and improve their clinical courses. The relationship ... monocyte ratio (LMR) at diagnosis and ovarian cancer prognosis has been ext...

    Authors: Jun Gong, Hui Jiang, Chang Shu, Mei-qin Hu, Yan Huang, Qin Liu and Rong-feng Li
    Citation: Journal of Ovarian Research 2019 12:51
  16. Ovarian cancer is the most lethal of all gynecologic ... The relationship between sexual steroids receptors and ovarian cancer progression has been largely evaluated. The presence ... obtained from 35 patients di...

    Authors: Enrique Pedernera, María J. Gómora, Flavia Morales-Vásquez, Delia Pérez-Montiel and Carmen Mendez
    Citation: Journal of Ovarian Research 2019 12:15
  17. Struma ovarii is a rare ovarian neoplasm that often appears malignant on conventional imaging. Pseudo-Meigs’ syndrome with ascites, pleural effusion, and elevated serum CA 125 levels is much rarer and leads to mi...

    Authors: Sayaka Fujiwara, Hideaki Tsuyoshi, Toshiya Nishimura, Nozomu Takahashi and Yoshio Yoshida
    Citation: Journal of Ovarian Research 2018 11:11
  18. Epithelial ovarian cancer has the highest fatality rate of all ... epithelial ovarian, fallopian tube, and primary peritoneal cancer.

    Authors: Samantha Cohen, Melissa Schwartz, Peter Dottino and Ann Marie Beddoe
    Citation: Journal of Ovarian Research 2019 12:36
  19. The low effectiveness of anticancer drugs remains a major unresolved obstacle to successful chemotherapy. Recently, much evidence on the roles of miRNAs in determining drug-sensitivity/resistance has been emergin...

    Authors: Yueping Zhan, Fenfen Xiang, Rong Wu, Jian Xu, Zhenhua Ni, Jiemin Jiang and Xiangdong Kang
    Citation: Journal of Ovarian Research 2015 8:48
  20. The aim of this study is to evaluate a new tumour marker, HE4, and to compare it with CA125 in predicting optimal cytoreduction and response to chemotherapy. Thirty patients with advanced epithelial ovarian cancer

    Authors: Aurélie Pelissier, Aurélie Roulot, Béatrice Guéry, Claire Bonneau, Dominique Bellet and Roman Rouzier
    Citation: Journal of Ovarian Research 2016 9:61
  21. Optimal cytoreduction (macroscopic Residual Tumor, RT = 0) is the best survival predictor factor in epithelial ovarian cancer (EOC). It doesn’t exist a...

    Authors: Eleonora Ghisoni, Dionyssios Katsaros, Furio Maggiorotto, Massimo Aglietta, Marco Vaira, Michele De Simone, Gloria Mittica, Gaia Giannone, Manuela Robella, Sofia Genta, Fabiola Lucchino, Francesco Marocco, Fulvio Borella, Giorgio Valabrega and Riccardo Ponzone
    Citation: Journal of Ovarian Research 2018 11:42
  22. To detected both pregnancy and oncologic outcomes early stage low grade epithelial ovarian cancer (EOC) in one tertiary hospital of...

    Authors: Jie Yin, Yongxue Wang, Ying Shan, Yan Li, Ying Jin and Lingya Pan
    Citation: Journal of Ovarian Research 2019 12:44
  23. No consensus exists on the outcome-related factors of interval debulking surgery (IDS) in patients with advanced high-grade serous ovarian cancer (HG-SOC) who underwent neoadjuvant chemotherapy...

    Authors: Xia Xu, Fei Deng, Mengmeng Lv, Binhui Ren, Wenwen Guo and Xiaoxiang Chen
    Citation: Journal of Ovarian Research 2016 9:85
  24. The treatment of newly diagnosed advanced epithelial ovarian cancer (EOC) was predicted by an ovarian cancer computed tomography (CT) evaluation model combined...

    Authors: Lu Qin, Huming Huang, Mengjie Chen, Yuejuan Liang and He Wang
    Citation: Journal of Ovarian Research 2018 11:49
  25. BH3 mimetics are a class of drugs that antagonize the Bcl-2 family of apoptosis inhibitors. We have previously shown that these compounds can potentiate the activity of carboplatin against several ovarian cancer ...

    Authors: Mohammed Najim Abed, Marwan Ibrahim Abdullah and Alan Richardson
    Citation: Journal of Ovarian Research 2016 9:25
  26. The critical role of the immune system in controlling cancer progression has become evident and immune modulatory ... cell and plasma cell infiltration in epithelial ovarian cancer (EOC).

    Authors: Sebastian Lundgren, Jonna Berntsson, Björn Nodin, Patrick Micke and Karin Jirström
    Citation: Journal of Ovarian Research 2016 9:21
  27. The aim of the present study was to investigate the prognostic significance of preoperative complete blood count inflammatory markers in women operated for invasive Epithelial Ovarian Cancer (EOC).

    Authors: Mehmet Ufuk Ceran, Umit Tasdemir, Eser Colak and Tayfun Güngör
    Citation: Journal of Ovarian Research 2019 12:16
  28. The aim of our study was to investigate the clinical features and expression levels of hypothalamic-pituitary-gonadal axis-related hormone receptors in low-grade serous ovarian cancer (LGSC).

    Authors: Zheng Feng, Hao Wen, Xingzhu Ju, Rui Bi, Xiaojun Chen, Wentao Yang and Xiaohua Wu
    Citation: Journal of Ovarian Research 2017 10:7
  29. In recent years the question of the lack of transparency in clinical research has been debated by clinicians, researchers, citizens and their representatives, authors and publishers. This is particularly importan...

    Authors: Anna Roberto, Silvia Radrezza and Paola Mosconi
    Citation: Journal of Ovarian Research 2018 11:28
  30. The detection of CA125 has been used in the follow up of ovarian cancer. At present, some scholars believe that ... the recurrence for postoperative patients with epithelial ovarian cancer, but in our clinical fo...

    Authors: Na Guo and Zhilan Peng
    Citation: Journal of Ovarian Research 2017 10:14
  31. Ovarian cancer (OC) is a type of gynaecological ... with high mortality in females. Serous ovarian cancer (SOC) is a distinct subtype of ... studies indicated that CYPA has critical impact on cancer progression. ...

    Authors: Zhi-Ying Qi, Fang Wang, Ying-Ying Yue, Xue-Wang Guo, Rui-Meng Guo, Hong-Lin Li and Yan-Ying Xu
    Citation: Journal of Ovarian Research 2019 12:118
  32. Ovarian cancer (OC) was the primary malignant gynecological cancer and SNARE protein is closely related with...

    Authors: Qi Sun, Xing Huang, Quanli Zhang, Junwei Qu, Yang Shen, Xin Wang, Haijun Sun, Jie Wang, Lin Xu, Xiaoxiang Chen and Binhui Ren
    Citation: Journal of Ovarian Research 2016 9:80
  33. The authors present the history and details of a 22-year-old woman with bilateral pelvic masses and a highly elevated serum CA-125 level (1,056 U/ml). Ultrasonography and magnetic resonance imaging (MRI) of the p...

    Authors: Nam Kyung Lee, Kyung Un Choi, Ga Jin Han, Byung Su Kwon, Yong Jung Song, Dong Soo Suh and Ki Hyung Kim
    Citation: Journal of Ovarian Research 2016 9:79
  34. Ovarian cancer is the most lethal gynaecologic malignancy. Although there are various subtypes of ovarian cancer, high-grade serous ovarian cancer (HGSOC) accounts for 70% of ovarian cancer deaths. Chemoresistanc...

    Authors: Huan Wu, Rongrong Li, Zhiwei Zhang, Huiyang Jiang, Hanlin Ma, Cunzhong Yuan, Chenggong Sun, Yingwei Li and Beihua Kong
    Citation: Journal of Ovarian Research 2019 12:125

    The Correction to this article has been published in Journal of Ovarian Research 2020 13:28

  35. The death-domain-associated protein (DAXX) was originally identified as a protein that binds to the transmembrane death receptor FAS and enhances both FAS-induced and transforming growth factor-β-dependent apopto...

    Authors: Sheng-Bing Liu, Xue-Ping Lin, Ying Xu, Zhong-Fei Shen and Wei-Wei Pan
    Citation: Journal of Ovarian Research 2018 11:90
  36. To investigate the expression of MMP-14 and CD44 as well as epithelial-to-mesenchymal transition(EMT)-like changes in ovarian cancer and to determine correlations with clinical outcome.

    Authors: Maria Caroline Vos, Eva Hollemans, Nicole Ezendam, Harry Feijen, Dorry Boll, Brenda Pijlman, Hans van der Putten, Paul Klinkhamer, Toin H. van Kuppevelt, Anneke A. M. van der Wurff and Leon F. A. G. Massuger
    Citation: Journal of Ovarian Research 2016 9:53
  37. Whether there is a mechanistic link between FOLR1 and response to cisplatin has not been extensively examined. In this study, we determine the expression of FOLR1 in ovarian cancer and examine if FOLR1 levels inf...

    Authors: Ming-ju Huang, Wei Zhang, Qi Wang, Zhi-jun Yang, Sheng-bin Liao and Li Li
    Citation: Journal of Ovarian Research 2018 11:15
  38. Ovarian carcinomas, usually associated with sex hormones dysregulation, are the leading cause of gynecological neoplastic death. In normal ovaries, hormones play a central role in regulating cell proliferation, d...

    Authors: Maíra A. Lima, Suély V. da Silva and Vanessa M. Freitas
    Citation: Journal of Ovarian Research 2016 9:9
  39. Lysine-specific demethylase 1(LSD1) is implicated in the tumorigenesis and progression in various cancers. However, the expression of LSD1 in epithelial ovarian cancer and its clinical significance has not been.....

    Authors: Cong Chen, Jing Ge, Qibin Lu, Guoqiang Ping, Chunqing Yang and Xuefeng Fang
    Citation: Journal of Ovarian Research 2015 8:28
  40. Growing evidence indicates that the tumor biomarker cytokeratin 19 fragment (CYFRA21-1) is significant for a variety of cancers. However, its role in epithelial ovarian cancer (EOC) has rarely been reported. In ....

    Authors: Chunjing Jin, Minfeng Yang, Xueqiao Han, Haidan Chu, Yan Zhang, Meihong Lu, Zhonghui Wang, Xinxin Xu, Wenwen Liu, Feng Wang and Shaoqing Ju
    Citation: Journal of Ovarian Research 2019 12:114

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

Editor News

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.